Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04824794
Title GEN3014 Safety Trial in Relapsed or Refractory Hematologic Malignancies
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Genmab
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | SWE | POL | NZL | NLD | HUN | GRC | FRA | ESP | DNK | CZE | AUS


No variant requirements are available.